The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue 1, 2009, Pages 154-159

  Ley, Eric J ^a   Scehnet, Jeff ^a   Park, Ryan ^a   Schroff, Stu ^a   Dagliyan, Grant ^a   Conti, Peter S ^a   Margulies, Daniel R ^a   Salim, Ali ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Beta blocker; Perfusion; Propranolol; Trauma; Traumatic brain injury

Indexed keywords

AGGLUTININ; CD31 ANTIGEN; COPPER 64; PLACEBO; PROPRANOLOL; COPPER PYRUVALDEHYDE BIS(N(4) METHYLTHIOSEMICARBAZONE) COMPLEX; COPPER PYRUVALDEHYDE BIS(N(4)-METHYLTHIOSEMICARBAZONE) COMPLEX; DIAGNOSTIC AGENT; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; THIOSEMICARBAZONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN PERFUSION; CONTROLLED STUDY; DRUG EFFECT; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RICINUS COMMUNIS; TRAUMATIC BRAIN INJURY; ANALYSIS OF VARIANCE; ANIMAL; ANOXIA; BAGG ALBINO MOUSE; BRAIN CIRCULATION; BRAIN INJURY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; NONPARAMETRIC TEST; RANDOMIZATION; SCINTISCANNING; STATISTICAL MODEL;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; BRAIN INJURIES; CEREBROVASCULAR CIRCULATION; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MICE; MICE, INBRED BALB C; ORGANOMETALLIC COMPOUNDS; PROPRANOLOL; RADIOPHARMACEUTICALS; RANDOM ALLOCATION; STATISTICS, NONPARAMETRIC; THIOSEMICARBAZONES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 67649228988     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31819388be     Document Type: Article

References (19)

1. Waxweiler RJ, Thurman D, Sniezek J, Sosin D, O'Neil J. Monitoring the impact of traumatic brain injury: a review and update. J Neurotrauma. 1995;12:509-516.
2. Maas AI, Marmarou A, Murray GD, Teasdale SG, Steyerberg EW. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007;24:232-238.
3. Inaba K, Teixeira PG, David JS, et al. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206:432-438.
4. Salim A, Hadjizacharia P, Brown C, et al. Significance of troponin elevation after severe traumatic brain injury. J Trauma. 2008;64:46-52.
5. Cotton BA, Snodgrass KB, Fleming SB, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62:26-33; discussion 33-35.
6. Riordan WP Jr, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA Jr.. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007;63:503-510; discussion 510-511.
7. Arbabi S, Campion EM, Hemmila MR, et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;62:56-61; discussion 61-62.
8. Liu MY. Protective effects of propranolol on experimentally head-injured mouse brains. J Formos Med Assoc. 1995;94:386-390.
9. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives. Nucl Med Biol. 2007;34:267-272.
10. Conti PS, Bading JR, Mouton PP, et al. In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET. Nucl Med Biol. 2008;35:131-141.
11. Edvinsson L, Lacombe P, Owman C, Reynier-Rebuffel AM, Seylaz J. Quantitative changes in regional cerebral blood flow of rats induced by alpha- and beta-adrenergic stimulants. Acta Physiol Scand. 1979;107:289-296.
12. Young H, Carnochan P, Zweit J, Babich J, Cherry S, Ott R. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET. J Nucl Biol Med. 1994;38(4 Suppl 1):89-91.
13. Green MA, Mathias CJ, Welch MJ, et al. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): Synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med. 1990;31:1989-96.
14. Lewis JS, McCarthy DW, McCarthy TJ, Fujibayashi Y, Welch MJ. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med. 1999;40:177-83.
15. Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus. 2007;22:E1.
16. Clifton GL, Grossman RG, Makela ME, Miner ME, Handel S, Sadhu V. Neurological course and correlated computerized tomography findings after severe closed head injury. J Neurosurg. 1980;52:611-624.
17. Hortnagl H, Hammerle AF, Hackl JM, Brücke T, Rumpl E, Hörtnagl H. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med. 1980;6:169-177.
18. Qu C, Mahmood A, Lu D, Xiong Y, Chopp M. Treatment of traumatic brain injury in mice with marrow stromal cells. Brain Res. 2008;1208:234-239.
19. Zhang ZX, Guan LX, Zhang K, Zhang Q, Dai LJ. A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy. 2008;10:134-139.